Literature DB >> 19823847

In pursuit of prognostic factors in children with pilocytic astrocytomas.

Aline Paixão Becker1, Ricardo Santos de Oliveira, Fabiano Pinto Saggioro, Luciano Neder, Leila Maria Cardão Chimelli, Hélio Rubens Machado.   

Abstract

OBJECTIVE: This study described a 23-year experience in the treatment of children with pilocytic astrocytomas (piloA) with the aim of identifying putative clinical, histopathological, and/or immunohistochemical features that could be related to the outcome of these patients.
METHODS: Clinical data of 31 patients under 18 years of age with piloA were obtained from 1984 to 2006.
RESULTS: The mean age at the time of surgery was 7.8 +/- 4.2 years (1 to 17 years), and the mean follow-up was 5.7 +/- 5.4 years (1 to 20 years). The most common site of tumor formation was the cerebellum (17), followed by brainstem (4), optic chiasmatic hypothalamic region (4), cerebral hemisphere (3), cervical spinal cord (2), and optic nerve (1). Gross total resection (GTR) was achieved in 23 (74.1%), mainly in those with tumors located in the cerebellum and cerebral hemispheres (P = 0.02). The global mortality rate was 6.4%. Nine patients were reoperated. Rosenthal fibers, eosinophilic granular bodies, microvascular proliferation, and lymphocytic infiltration were observed in most cases. The mean Ki-67LI was 4.4 +/- 4.5%. In all cases, Gal-3 expression in tumor cells was observed with variable staining pattern.
CONCLUSIONS: Aside from GTR, no other clinical, histopathological, or immunohistochemical features were found to be related to the prognosis. We postulate that strict follow-up is recommended if piloA is associated with high mitotic activity/Ki67-LI, or if GTR cannot be achieved at surgery. Tumor recurrence or progression of the residual lesion should be strictly observed. In some aspects, childhood piloA remains an enigmatic tumor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19823847     DOI: 10.1007/s00381-009-0990-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  45 in total

1.  Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.

Authors:  Mário H G Faria; Bronner P A Gonçalves; Régia M do S V do Patrocínio; Manoel O de Moraes-Filho; Silvia H B Rabenhorst
Journal:  Neuropathology       Date:  2006-12       Impact factor: 1.906

2.  Postoperative surveillance imaging in children with cerebellar astrocytomas.

Authors:  L N Sutton; A Cnaan; L Klatt; H Zhao; R Zimmerman; M Needle; P Molloy; P Phillips
Journal:  J Neurosurg       Date:  1996-05       Impact factor: 5.115

3.  MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.

Authors:  L Neder; B O Colli; H R Machado; C G Carlotti; A C Santos; L Chimelli
Journal:  Clin Neuropathol       Date:  2004 Nov-Dec       Impact factor: 1.368

Review 4.  Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature.

Authors:  C M Dirven; J J Mooij; W M Molenaar
Journal:  Childs Nerv Syst       Date:  1997-01       Impact factor: 1.475

5.  Survival of children with infratentorial neuroglial tumors. The Childhood Brain Tumor Consortium.

Authors:  E L Sobel; F H Gilles; A Leviton; C J Tavaré; E T Hedley-Whyte; L B Rorke; L S Adelman
Journal:  Neurosurgery       Date:  1996-07       Impact factor: 4.654

6.  Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma.

Authors:  A N Mamelak; M D Prados; W G Obana; P H Cogen; M S Edwards
Journal:  J Neurosurg       Date:  1994-07       Impact factor: 5.115

7.  Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology.

Authors:  M Preusser; U Laggner; C Haberler; H Heinzl; H Budka; J A Hainfellner
Journal:  Histopathology       Date:  2006-03       Impact factor: 5.087

8.  Benign cerebellar astrocytomas in children.

Authors:  P Pencalet; W Maixner; C Sainte-Rose; A Lellouch-Tubiana; G Cinalli; M Zerah; A Pierre-Kahn; E Hoppe-Hirsch; M Bourgeois; D Renier
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

9.  Benign cerebellar astrocytomas of childhood.

Authors:  J H Schneider; C Raffel; J G McComb
Journal:  Neurosurgery       Date:  1992-01       Impact factor: 4.654

10.  Analysis of the extent of astrocytic tumour resection evaluated by magnetic resonance images.

Authors:  Masato Ohki; Kaori Sakurada; Yukihiko Sonoda; Shinya Sato; Shinjiro Saito; Takamasa Kayama
Journal:  Neurosurg Rev       Date:  2003-06-19       Impact factor: 3.042

View more
  8 in total

Review 1.  Gamma Knife treatment of low-grade gliomas in children.

Authors:  Murat Şakir Ekşi; Baran Yılmaz; Akın Akakın; Zafer Orkun Toktaş; Ahmet Cemil Kaur; Mustafa Kemal Demir; Türker Kılıç
Journal:  Childs Nerv Syst       Date:  2015-07-15       Impact factor: 1.475

2.  Overexpression of mTOR and p(240-244)S6 in IDH1 Wild-Type Human Glioblastomas Is Predictive of Low Survival.

Authors:  Luis Eduardo Machado; Arthur William Alvarenga; Fernanda Ferreira da Silva; Martín Roffé; Maria Dirlei Begnami; Luís Fernando Bleggi Torres; Isabela Werneck da Cunha; Vilma Regina Martins; Glaucia Noeli Maroso Hajj
Journal:  J Histochem Cytochem       Date:  2018-01-12       Impact factor: 2.479

3.  Evaluation of Akt and RICTOR Expression Levels in Astrocytomas of All Grades.

Authors:  Arthur William Alvarenga; Luis Eduardo Machado; Bruna Roz Rodrigues; Fernanda Cristina Sulla Lupinacci; Paulo Sanemastu; Eduardo Matta; Martín Roffé; Luís Fernando Bleggi Torres; Isabela Werneck da Cunha; Vilma Regina Martins; Glaucia Noeli Maroso Hajj
Journal:  J Histochem Cytochem       Date:  2016-10-28       Impact factor: 2.479

4.  Galectin-3 expression: a useful tool in the differential diagnosis of posterior fossa tumors in children.

Authors:  Carolina Bisinoto Borges; Emerson Soares Bernardes; Elder Francisco Latorraca; Aline Paixão Becker; Luciano Neder; Roger Chammas; Maria Cristina Roque-Barreira; Hélio Rubens Machado; Ricardo Santos de Oliveira
Journal:  Childs Nerv Syst       Date:  2010-08-14       Impact factor: 1.475

Review 5.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

6.  Whole Chromosome 7 Gain Predicts Higher Risk of Recurrence in Pediatric Pilocytic Astrocytomas Independently From KIAA1549-BRAF Fusion Status.

Authors:  Jacquelyn J Roth; Tamara M Fierst; Angela J Waanders; Li Yimei; Jaclyn A Biegel; Mariarita Santi
Journal:  J Neuropathol Exp Neurol       Date:  2016-03-04       Impact factor: 3.685

7.  Management of posterior fossa gliomas in children.

Authors:  K Sridhar; R Sridhar; G Venkatprasanna
Journal:  J Pediatr Neurosci       Date:  2011-10

8.  KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.

Authors:  Aline Paixão Becker; Cristovam Scapulatempo-Neto; Adriana C Carloni; Alessandra Paulino; Jamie Sheren; Dara L Aisner; Evelyn Musselwhite; Carlos Clara; Hélio R Machado; Ricardo S Oliveira; Luciano Neder; Marileila Varella-Garcia; Rui M Reis
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.